# Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test

> **NCT04635384** · — · ACTIVE_NOT_RECRUITING · sponsor: **CareDx** · enrollment: 307 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Myelodysplastic Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04635384
- **Lead sponsor:** CareDx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-06-30
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04635384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04635384, "Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04635384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*